TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
RaySearch Laboratories AB (publ)
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
103,777
|
92,120
|
75,811 |
| Financial expenses |
788
|
874
|
1,031 |
| Earnings before taxes |
22,885
|
9,921
|
2,909 |
| EBITDA |
48,741
|
20,566
|
13,237 |
| Total assets |
182,056
|
175,979
|
168,575 |
| Current assets |
85,731
|
72,318
|
56,426 |
| Current liabilities |
61,274
|
60,837
|
55,183 |
| Equity capital |
76,325
|
66,261
|
59,053 |
| - share capital |
1,492
|
1,545
|
1,540 |
| Employees (average) |
408
|
376
|
382 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
41.9%
|
37.7%
|
35.0% |
| Turnover per employee |
254
|
245
|
198 |
| Profit as a percentage of turnover |
22.1%
|
10.8%
|
3.8% |
| Return on assets (ROA) |
13.0%
|
6.1%
|
2.3% |
| Current ratio |
139.9%
|
118.9%
|
102.3% |
| Return on equity (ROE) |
30.0%
|
15.0%
|
4.9% |
| Change turnover |
14,789
|
16,088
|
18,150 |
| Change turnover % |
17%
|
21%
|
31% |
| Chg. No. of employees |
32
|
-6
|
-36 |
| Chg. No. of employees % |
9%
|
-2%
|
-9% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.